NDC 10157-9861

Blistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration)

Dimethicone, Octinoxate, Oxybenzone, Avobenzone, And Octocrylene

Blistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration) is a Kit in the Human Otc Drug category. It is labeled and distributed by Blistex Inc.. The primary component is .

Product ID10157-9861_1ca96f35-dd94-4839-8985-76c0fe6b9b38
NDC10157-9861
Product TypeHuman Otc Drug
Proprietary NameBlistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration)
Generic NameDimethicone, Octinoxate, Oxybenzone, Avobenzone, And Octocrylene
Dosage FormKit
Marketing Start Date2014-09-01
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart347
Labeler NameBlistex Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 10157-9861-1

1 KIT in 1 BLISTER PACK (10157-9861-1) * 3.69 g in 1 CYLINDER * 3.69 g in 1 CYLINDER * 3.69 g in 1 CYLINDER
Marketing Start Date2014-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10157-9861-1 [10157986101]

Blistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration) KIT
Marketing CategoryOTC monograph final
Application Numberpart347
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-09-01
Inactivation Date2020-01-31

Drug Details

OpenFDA Data

SPL SET ID:6930ccd8-51ed-43d5-919c-3941937afa2e
Manufacturer
UPC Code
  • 0041388004358
  • NDC Crossover Matching brand name "Blistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration)" or generic name "Dimethicone, Octinoxate, Oxybenzone, Avobenzone, And Octocrylene"

    NDCBrand NameGeneric Name
    10157-9861Blistex Enhancement Series (Lip Vibrance, Deep Renewal and Ultra-Rich Hydration)Dimethicone, Octinoxate, Oxybenzone, Avobenzone, and Octocrylene
    10157-9858BlistexDimethicone, Octinoxate, Oxybenzone, Avobenzone, and Octocrylene

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.